These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
633 related articles for article (PubMed ID: 25605241)
41. PD-L1 induces epithelial-to-mesenchymal transition via activating SREBP-1c in renal cell carcinoma. Wang Y; Wang H; Zhao Q; Xia Y; Hu X; Guo J Med Oncol; 2015 Aug; 32(8):212. PubMed ID: 26141060 [TBL] [Abstract][Full Text] [Related]
42. KDM6B induces epithelial-mesenchymal transition and enhances clear cell renal cell carcinoma metastasis through the activation of SLUG. Li Q; Hou L; Ding G; Li Y; Wang J; Qian B; Sun J; Wang Q Int J Clin Exp Pathol; 2015; 8(6):6334-44. PubMed ID: 26261509 [TBL] [Abstract][Full Text] [Related]
43. DCLK1 facilitates intestinal tumor growth via enhancing pluripotency and epithelial mesenchymal transition. Chandrakesan P; Weygant N; May R; Qu D; Chinthalapally HR; Sureban SM; Ali N; Lightfoot SA; Umar S; Houchen CW Oncotarget; 2014 Oct; 5(19):9269-80. PubMed ID: 25211188 [TBL] [Abstract][Full Text] [Related]
44. Activation of aryl hydrocarbon receptor promotes invasion of clear cell renal cell carcinoma and is associated with poor prognosis and cigarette smoke. Ishida M; Mikami S; Shinojima T; Kosaka T; Mizuno R; Kikuchi E; Miyajima A; Okada Y; Oya M Int J Cancer; 2015 Jul; 137(2):299-310. PubMed ID: 25523818 [TBL] [Abstract][Full Text] [Related]
45. Downregulation of FOXO3a promotes tumor metastasis and is associated with metastasis-free survival of patients with clear cell renal cell carcinoma. Ni D; Ma X; Li HZ; Gao Y; Li XT; Zhang Y; Ai Q; Zhang P; Song EL; Huang QB; Fan Y; Zhang X Clin Cancer Res; 2014 Apr; 20(7):1779-90. PubMed ID: 24486593 [TBL] [Abstract][Full Text] [Related]
46. Doublecortin and CaM kinase-like-1 as an independent prognostic factor in patients with resected pancreatic carcinoma. Nishio K; Kimura K; Amano R; Nakata B; Yamazoe S; Ohira G; Miura K; Kametani N; Tanaka H; Muguruma K; Hirakawa K; Ohira M World J Gastroenterol; 2017 Aug; 23(31):5764-5772. PubMed ID: 28883702 [TBL] [Abstract][Full Text] [Related]
47. [Expression of LIM and SH3 protein 1 in renal clear cell carcinoma and its effects on invasion and migration of renal clear cell carcinoma 786-O cells]. Jin B; Gao L; Li W; Chen JC; Wen RM; Wang JQ Zhonghua Zhong Liu Za Zhi; 2017 Mar; 39(3):166-171. PubMed ID: 28316213 [No Abstract] [Full Text] [Related]
48. CXC chemokine receptor 4 is essential for maintenance of renal cell carcinoma-initiating cells and predicts metastasis. Gassenmaier M; Chen D; Buchner A; Henkel L; Schiemann M; Mack B; Schendel DJ; Zimmermann W; Pohla H Stem Cells; 2013 Aug; 31(8):1467-76. PubMed ID: 23630186 [TBL] [Abstract][Full Text] [Related]
50. Inhibition of LEF1-Mediated DCLK1 by Niclosamide Attenuates Colorectal Cancer Stemness. Park SY; Kim JY; Choi JH; Kim JH; Lee CJ; Singh P; Sarkar S; Baek JH; Nam JS Clin Cancer Res; 2019 Feb; 25(4):1415-1429. PubMed ID: 30446587 [TBL] [Abstract][Full Text] [Related]
51. Dicer is down-regulated in clear cell renal cell carcinoma and in vitro Dicer knockdown enhances malignant phenotype transformation. Ma X; Fan Y; Gao Y; Zhang Y; Huang Q; Ai Q; Ni D; Chen W; Zhang P; Song E; Wang B; Shi T; Zheng T; Zhang X Urol Oncol; 2014 Jan; 32(1):46.e9-17. PubMed ID: 24094887 [TBL] [Abstract][Full Text] [Related]
52. Genetic and epigenetic control of UNC5C expression in human renal cell carcinoma. Lv D; Zhao W; Dong D; Qian XP; Zhang Y; Tian XJ; Zhang J Eur J Cancer; 2011 Sep; 47(13):2068-76. PubMed ID: 21600761 [TBL] [Abstract][Full Text] [Related]
53. miR-17 inhibition enhances the formation of kidney cancer spheres with stem cell/ tumor initiating cell properties. Lichner Z; Saleh C; Subramaniam V; Seivwright A; Prud'homme GJ; Yousef GM Oncotarget; 2015 Mar; 6(8):5567-81. PubMed ID: 25011053 [TBL] [Abstract][Full Text] [Related]
54. OVOL2 links stemness and metastasis via fine-tuning epithelial-mesenchymal transition in nasopharyngeal carcinoma. Qi XK; Han HQ; Zhang HJ; Xu M; Li L; Chen L; Xiang T; Feng QS; Kang T; Qian CN; Cai MY; Tao Q; Zeng YX; Feng L Theranostics; 2018; 8(8):2202-2216. PubMed ID: 29721073 [No Abstract] [Full Text] [Related]
55. MicroRNA-126 inhibits tumor cell invasion and metastasis by downregulating ROCK1 in renal cell carcinoma. Zhang GM; Luo L; Ding XM; Dong DH; Li B; Ma XC; Sun LJ Mol Med Rep; 2016 Jun; 13(6):5029-2036. PubMed ID: 27108693 [TBL] [Abstract][Full Text] [Related]
56. Long non-coding RNA HOTAIR promotes cell migration by upregulating insulin growth factor-binding protein 2 in renal cell carcinoma. Katayama H; Tamai K; Shibuya R; Nakamura M; Mochizuki M; Yamaguchi K; Kawamura S; Tochigi T; Sato I; Okanishi T; Sakurai K; Fujibuchi W; Arai Y; Satoh K Sci Rep; 2017 Sep; 7(1):12016. PubMed ID: 28931862 [TBL] [Abstract][Full Text] [Related]
57. TNF-α induces epithelial-mesenchymal transition of renal cell carcinoma cells via a GSK3β-dependent mechanism. Ho MY; Tang SJ; Chuang MJ; Cha TL; Li JY; Sun GH; Sun KH Mol Cancer Res; 2012 Aug; 10(8):1109-19. PubMed ID: 22707636 [TBL] [Abstract][Full Text] [Related]
58. miR-144-3p serves as a tumor suppressor for renal cell carcinoma and inhibits its invasion and metastasis by targeting MAP3K8. Liu F; Chen N; Xiao R; Wang W; Pan Z Biochem Biophys Res Commun; 2016 Nov; 480(1):87-93. PubMed ID: 27717821 [TBL] [Abstract][Full Text] [Related]
59. Up-regulation of glycolysis promotes the stemness and EMT phenotypes in gemcitabine-resistant pancreatic cancer cells. Zhao H; Duan Q; Zhang Z; Li H; Wu H; Shen Q; Wang C; Yin T J Cell Mol Med; 2017 Sep; 21(9):2055-2067. PubMed ID: 28244691 [TBL] [Abstract][Full Text] [Related]
60. Silencing of tumor-suppressive NR_023387 in renal cell carcinoma via promoter hypermethylation and HNF4A deficiency. Zhou H; Guo L; Yao W; Shi R; Yu G; Xu H; Ye Z J Cell Physiol; 2020 Mar; 235(3):2113-2128. PubMed ID: 31432508 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]